Dialog Box

Ovarian Cancer Symposium

The changing world of ovarian cancer treatment

7:00PM - 9:00PM Tuesday 15th June 2021

Ovarian Cancer Australia is bringing together leading Australian and international researchers, clinicians and industry representatives for a virtual independent ovarian cancer symposium for health professionals. This is your opportunity to find out about the latest developments and advances in the rapidly evolving field of ovarian cancer research and treatment. 

Session topics & dates

Session 1: Genomics

15th June, 7:00 - 9:00 pm AEST

Session 2: Immunotherapy and Targeted Therapy

18th June, 9:00 - 11:00 am AEST

Session 3: Tumour Board Discussion

22nd June, 7:00 - 9:00 pm AEST

Session 4: PARP Inhibitors

25th June, 9:00 - 11:00 am AEST

Event informationEvent program

International Speakers

Professor Charlie Gourley

Clinical Director, Cancer Research UK Edinburgh Centre 

Professor and Honorary Consultant in Medical Oncology, The University of Edinburgh

Molecular stratification of endometrioid ovarian carcinoma

Dr Kathleen N. Moore, MD, MS

Associate Director Clinical Research,
Associate Professor, Section of Gynecologic Oncology,

Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center

Changes and challenges in the treatment paradigm for front line ovarian cancer.

Dr Ahmed Ahmed, MD, PhD

Professor of Gynaecological Oncology, Director of the Ovarian Cancer Cell Laboratory, University of Oxford

The Oxford Classic and the story of the “SPARC cluster”.

Dr Alan D. D'Andrea, MD

Director, Center for DNA Damage and Repair,

Director, Susan F. Smith Center for Women’s Cancers at the Fuller-American Cancer Society

Professor, Harvard Medical School, Dana-Farber Cancer Institute, Boston

A first-in-class Polymerase Theta Inhibitor selectively targets Homologous Recombination-Deficient Tumour.

Dr Elise Kohn, MD CAPT, USPHS, Fellow AAAS

Head, Gynecologic and Neuroendocrine Cancer Therapeutics

Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute

Not your average DNA damage: leveraging underlying DNA repair dysfunction for benefit.

Guest Speakers and Panel Members: 

Prof Anna DeFazio • A/Prof Phillip Beale • A/Prof Clare Scott • A/Prof Kylie Gorringe • A/Prof Lyndal Anderson • A/Prof Alison Brand • Dr Tarek Meniawy • Dr Elaine Sanij • Dr Dale Garsed • Dr Tania Moujaber

Who should attend?

Gynaecological Oncologists

Medical Oncologists


Oncologists in training

Gynaecological Nurse Consultants

Genetic Counsellors

Register for event Contact organiser

Please note:

Please use a laptop or desktop computer (not your mobile phone) for the event. 

If you are interested, we can arrange a technical rehearsal with you.